Cranial mononeuropathy VII

Injury	Disease	Nutrition	Poison

Symptoms	Surgery	Test	Special Topic

Central nervous system

Overview

Symptoms

Treatment

Prevention

Cranial mononeuropathy VII

Alternative Names:

Neuropathy - facial; Facial nerve palsy

Treatment:

Identification and treatment of the underlying cause (if it can be identified) may relieve symptoms for some people. The disorder may disappear on its own depending on the severity of damage to the nerve.

Corticosteroids may reduce swelling and relieve pressure on the facial nerve. Acyclovir, an antiviral agent, is used in conjunction with steroids. Lubricating eye drops or eye ointments may be recommended to protect the eye if it cannot be closed completely.

The eye may need to be patched during sleep to protect it.

Surgery to decompress the facial nerve may be recommended if a tumor is identified.

Expectations (prognosis):

The outcome varies. Some patients recover completely; others experience a permanent loss of facial movement.

Complications:

Disfigurement from loss of facial movement
Damage to the eye (corneal ulcers and infections)
Chronic spasm of face muscles or eyelids
Chronic taste abnormalities
Aberrant regeneration (nerves grow back to the wrong structures -- for example, smiling causes the eye to close)

Calling your health care provider:

Call your health care provider if facial drooping or other symptoms of cranial mononeuropathy VII occur.

Review Date: 8/1/2004
Reviewed By: Joseph V. Campellone, M.D., Division of Neurology, Cooper University Hospital, Camden, NJ. Review provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.